TY - JOUR AU - Felson, D. T. AU - Anderson, J. J. AU - Boers, M. AU - Bombardier, C. AU - Chernoff, M. AU - Fried, B. PY - 1993 DA - 1993// TI - The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials JO - Arthritis Rheum VL - 36 UR - https://doi.org/10.1002/art.1780360601 DO - 10.1002/art.1780360601 ID - Felson1993 ER - TY - JOUR AU - Kirwan, J. R. AU - Hewlett, S. E. AU - Heiberg, T. AU - Hughes, R. A. AU - Carr, M. AU - Hehir, M. PY - 2005 DA - 2005// TI - Incorporating the patient perspective into outcome assessment in rheumatoid arthritis–progress at OMERACT 7 JO - J Rheumatol VL - 32 ID - Kirwan2005 ER - TY - JOUR AU - Kirwan, J. R. AU - Tugwell, P. S. PY - 2011 DA - 2011// TI - Overview of the patient perspective at OMERACT 10–conceptualizing methods for developing patient-reported outcomes JO - J Rheumatol VL - 38 UR - https://doi.org/10.3899/jrheum.110388 DO - 10.3899/jrheum.110388 ID - Kirwan2011 ER - TY - JOUR AU - Genovese, M. C. AU - Fleischmann, R. AU - Kivitz, A. J. AU - Rell-Bakalarska, M. AU - Martincova, R. AU - Fiore, S. PY - 2015 DA - 2015// TI - Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a phase III Study JO - Arthritis Rheumatol VL - 67 UR - https://doi.org/10.1002/art.39093 DO - 10.1002/art.39093 ID - Genovese2015 ER - TY - JOUR AU - Schaible, H. G. PY - 2014 DA - 2014// TI - Nociceptive neurons detect cytokines in arthritis JO - Arthritis Res Ther VL - 16 UR - https://doi.org/10.1186/s13075-014-0470-8 DO - 10.1186/s13075-014-0470-8 ID - Schaible2014 ER - TY - JOUR AU - Rohleder, N. AU - Aringer, M. AU - Boentert, M. PY - 2012 DA - 2012// TI - Role of interleukin-6 in stress, sleep, and fatigue JO - Ann NY Acad Sci. VL - 1261 UR - https://doi.org/10.1111/j.1749-6632.2012.06634.x DO - 10.1111/j.1749-6632.2012.06634.x ID - Rohleder2012 ER - TY - JOUR AU - Bruce, B. AU - Fries, J. F. PY - 2003 DA - 2003// TI - The Stanford Health Assessment Questionnaire: dimensions and practical applications JO - Health Qual Life Outcomes. VL - 1 UR - https://doi.org/10.1186/1477-7525-1-20 DO - 10.1186/1477-7525-1-20 ID - Bruce2003 ER - TY - JOUR AU - Heijde, D. PY - 2000 DA - 2000// TI - How to read radiographs according to the Sharp/van der Heijde method JO - J Rheumatol VL - 27 ID - Heijde2000 ER - TY - JOUR AU - Arnett, F. C. AU - Edworthy, S. M. AU - Bloch, D. A. AU - McShane, D. J. AU - Fries, J. F. AU - Cooper, N. S. PY - 1988 DA - 1988// TI - The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis JO - Arthritis Rheum VL - 31 UR - https://doi.org/10.1002/art.1780310302 DO - 10.1002/art.1780310302 ID - Arnett1988 ER - TY - JOUR AU - Cella, D. AU - Yount, S. AU - Sorensen, M. AU - Chartash, E. AU - Sengupta, N. AU - Grober, J. PY - 2005 DA - 2005// TI - Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis JO - J Rheumatol VL - 32 ID - Cella2005 ER - TY - BOOK AU - Ware, J. E. AU - Kosinski, M. AU - Bjorner, J. B. AU - Turner-Bowker, D. AU - Maruish, M. E. PY - 2007 DA - 2007// TI - User’s manual for the SF-36v2™ Health Survey PB - QualityMetric Incorporated CY - Lincoln ID - Ware2007 ER - TY - JOUR AU - Wells, G. A. AU - Tugwell, P. AU - Kraag, G. R. AU - Baker, P. R. AU - Groh, J. AU - Redelmeier, D. A. PY - 1993 DA - 1993// TI - Minimum important difference between patients with rheumatoid arthritis: the patient’s perspective JO - J Rheumatol VL - 20 ID - Wells1993 ER - TY - JOUR AU - Strand, V. AU - Boers, M. AU - Idzerda, L. AU - Kirwan, J. R. AU - Kvien, T. K. AU - Tugwell, P. S. PY - 2011 DA - 2011// TI - It’s good to feel better but it’s better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10 JO - J Rheumatol VL - 38 UR - https://doi.org/10.3899/jrheum.110392 DO - 10.3899/jrheum.110392 ID - Strand2011 ER - TY - JOUR AU - Strand, V. AU - Smolen, J. S. AU - Vollenhoven, R. F. AU - Mease, P. AU - Burmester, G. R. AU - Hiepe, F. PY - 2011 DA - 2011// TI - Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial JO - Ann Rheum Dis VL - 70 UR - https://doi.org/10.1136/ard.2010.143586 DO - 10.1136/ard.2010.143586 ID - Strand2011 ER - TY - JOUR AU - Dworkin, R. H. AU - Turk, D. C. AU - Wyrwich, K. W. AU - Beaton, D. AU - Cleeland, C. S. AU - Farrar, J. T. PY - 2008 DA - 2008// TI - Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations JO - J Pain VL - 9 UR - https://doi.org/10.1016/j.jpain.2007.09.005 DO - 10.1016/j.jpain.2007.09.005 ID - Dworkin2008 ER - TY - JOUR AU - Lubeck, D. P. PY - 2004 DA - 2004// TI - Patient-reported outcomes and their role in the assessment of rheumatoid arthritis JO - Pharmacoeconomics. VL - 22 ID - Lubeck2004 ER - TY - JOUR AU - Osiri, M. AU - Suarez-Almazor, M. E. AU - Wells, G. A. AU - Robinson, V. AU - Tugwell, P. PY - 2003 DA - 2003// TI - Number needed to treat (NNT): implication in rheumatology clinical practice JO - Ann Rheum Dis VL - 62 UR - https://doi.org/10.1136/ard.62.4.316 DO - 10.1136/ard.62.4.316 ID - Osiri2003 ER - TY - JOUR AU - Heiberg, T. AU - Kvien, T. K. AU - Mowinckel, P. AU - Aletaha, D. AU - Smolen, J. S. AU - Hagen, K. B. PY - 2008 DA - 2008// TI - Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis JO - Ann Rheum Dis VL - 67 UR - https://doi.org/10.1136/ard.2007.077503 DO - 10.1136/ard.2007.077503 ID - Heiberg2008 ER - TY - JOUR AU - Rendas-Baum, R. AU - Bayliss, M. AU - Kosinski, M. AU - Raju, A. AU - Zwillich, S. H. AU - Wallenstein, G. V. PY - 2014 DA - 2014// TI - Measuring the effect of therapy in rheumatoid arthritis clinical trials from the patient’s perspective JO - Curr Med Res Opin VL - 30 UR - https://doi.org/10.1185/03007995.2014.896328 DO - 10.1185/03007995.2014.896328 ID - Rendas-Baum2014 ER - TY - JOUR AU - Hewlett, S. AU - Carr, M. AU - Ryan, S. AU - Kirwan, J. AU - Richards, P. AU - Carr, A. PY - 2005 DA - 2005// TI - Outcomes generated by patients with rheumatoid arthritis: how important are they? JO - Musculoskeletal Care VL - 3 UR - https://doi.org/10.1002/msc.3 DO - 10.1002/msc.3 ID - Hewlett2005 ER - TY - JOUR AU - Mease, P. AU - Strand, V. AU - Shalamberidze, L. AU - Dimic, A. AU - Raskina, T. AU - Xu, L. A. PY - 2012 DA - 2012// TI - A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate JO - Ann Rheum Dis VL - 71 UR - https://doi.org/10.1136/annrheumdis-2011-200704 DO - 10.1136/annrheumdis-2011-200704 ID - Mease2012 ER - TY - JOUR AU - Strand, V. AU - Mease, P. AU - Burmester, G. R. AU - Nikai, E. AU - Coteur, G. AU - Vollenhoven, R. PY - 2009 DA - 2009// TI - Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial JO - Arthritis Res Ther VL - 11 UR - https://doi.org/10.1186/ar2859 DO - 10.1186/ar2859 ID - Strand2009 ER - TY - JOUR AU - Strand, V. AU - Kremer, J. AU - Wallenstein, G. AU - Kanik, K. S. AU - Connell, C. AU - Gruben, D. PY - 2015 DA - 2015// TI - Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs JO - Arthritis Res Ther. VL - 17 UR - https://doi.org/10.1186/s13075-015-0825-9 DO - 10.1186/s13075-015-0825-9 ID - Strand2015 ER - TY - JOUR AU - Strand, V. AU - Kosinski, M. AU - Gnanasakthy, A. AU - Mallya, U. AU - Mpofu, S. PY - 2014 DA - 2014// TI - Secukinumab treatment in rheumatoid arthritis is associated with incremental benefit in the clinical outcomes and HRQoL improvements that exceed minimally important thresholds JO - Health Qual Life Outcomes. VL - 12 UR - https://doi.org/10.1186/1477-7525-12-31 DO - 10.1186/1477-7525-12-31 ID - Strand2014 ER -